Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP.
about
Management of fibrosis: the mesenchymal stromal cells breakthroughChanges in metalloproteinase and tissue inhibitor of metalloproteinase during tachycardia-induced cardiomyopathy by rapid atrial pacing in dogs.Changes in connexin 43, metalloproteinase and tissue inhibitor of metalloproteinase during tachycardia-induced cardiomyopathy in dogs.Quantifying the proteolytic release of extracellular matrix-sequestered VEGF with a computational model.Pharmacogenetic associations of MMP9 and MMP12 variants with cardiovascular disease in patients with hypertension.Mediators of mast cells in bullous pemphigoid and dermatitis herpetiformis.Metalloproteinase in myocardial adaptation and maladaptation.Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver.S-nitrosylation: specificity, occupancy, and interaction with other post-translational modifications.Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.The role of B-cells in heart failurePacing-induced cardiomyopathy: pathophysiological insights through matrix metalloproteinases.Matrix metalloproteinases are involved in cardiovascular diseases.Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice.Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension.A role of matrix metalloproteinase-8 in atherosclerosis.The effect of captopril on the expression of MMP-9 and the prognosis of neurological function in herpes simplex encephalitis mice.Captopril and lisinopril only inhibit matrix metalloproteinase-2 (MMP-2) activity at millimolar concentrations.A New Hypothesis for Insulin Resistance in Hypertension Due to Receptor Cleavage.Apoptosis after reperfused myocardial infarction: Role of angiotensin II.Serum concentrations of metalloproteinase 2, metalloproteinase 9 and granzyme B in contact eczema patients.Bone marrow mesenchymal stem cell transplantation combined with perindopril treatment attenuates infarction remodelling in a rat model of acute myocardial infarction.Dissecting the Role of the Extracellular Matrix in Heart Disease: Lessons from the Drosophila Genetic Model.Two MMP-2 promoter polymorphisms (-790T/G and -735C/T) in chronic heart failure.Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction.Physiological regulation of MMPs and tPA/PAI in the arterial wall of rats by noradrenergic tone and angiotensin II.Endogenous Annexin-A1 Regulates Haematopoietic Stem Cell Mobilisation and Inflammatory Response Post Myocardial Infarction in Mice In Vivo.Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study.Type IV collagen degradation in the myocardial basement membrane after unloading of the failing heart by a left ventricular assist device.Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure.Transactivation of the epidermal growth factor receptor by angiotensin II in glomerular podocytes.Histological and biochemical outcomes of cardiac pathology in mdx mice with dietary quercetin enrichment.
P2860
Q26827231-A22848A0-A236-42F6-A32E-E79B00FB737AQ33239800-A0C1973F-8966-4AD8-A7AB-052F38107225Q33249346-80EAC117-6665-4042-A934-4D1EC052071DQ33649673-CFF7E663-495D-43D1-88A6-0CA9B0C23A76Q34009450-672E11D2-0B0F-42B7-8F7D-09A44E3C75E0Q34460959-C8A99E8A-7ECA-4CEC-955F-6254C250F1D7Q35030016-E796B6F4-C0C0-4F56-8F9F-340148AE6DE6Q36915712-227EF519-06C6-4B6A-8069-DF152BCABEA2Q37204147-D3A9C885-4E0D-4E70-82EA-E47FD1BD76F9Q37774392-C4FAA9A9-2D8F-41C0-9850-7CA86C0A192AQ38091933-74BD2574-776B-4716-AEE2-9D3A9828B878Q38121745-9920CF28-0744-448B-BA3F-0EA3097646FBQ38224193-78D3EDAE-8BA8-4488-9E1C-0ADD9F41BD45Q38584976-EAA7D11D-D47B-4515-8D71-400535BCF392Q39255610-A31D04A8-19A3-4EAB-A54D-1DACDA327E17Q40000765-69167DDC-88EC-4D69-A96C-6308C064C892Q40632807-91766019-2F8C-476D-BDF0-54FDE6953547Q41230502-9C42DEA6-9A45-40F4-9981-B0431ACBFCB4Q41343627-963F1C06-313D-423B-A455-B4733A624E25Q42078470-95786DED-F0BB-420D-AEC3-79FF1C64A06DQ42154116-C5C04050-9AE2-4037-9003-046173D0BE99Q42457121-6D1EFD6C-007F-4574-8056-F096A535A004Q43378616-BF40774A-25DE-4450-986E-227BA81160F9Q44633040-C81D2355-7D2D-4AB2-B14F-7F184773422FQ45858813-8FE42173-E0EA-4DFB-B83D-0CBA2AB10AADQ46916695-88AD536D-B018-49B7-843F-EF95178881E6Q47098423-D07483D6-C71E-4388-B9A2-709F0F94D263Q47960038-EC6B49A8-9C1E-4548-BB64-799CB8D2C33EQ50909884-39B39739-2E20-4AD3-8092-3D623306DF20Q51994063-FB7381C6-1A1D-4406-8FC4-21BA72E1FE08Q53631060-7808A4EB-5A43-48BB-A11C-421D380ABD3FQ53646470-8B808984-9D32-4CB0-909A-1CD49126FBEF
P2860
Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Cardiac remodelling in end sta ...... fect of ACE inhibitors on MMP.
@ast
Cardiac remodelling in end sta ...... fect of ACE inhibitors on MMP.
@en
type
label
Cardiac remodelling in end sta ...... fect of ACE inhibitors on MMP.
@ast
Cardiac remodelling in end sta ...... fect of ACE inhibitors on MMP.
@en
prefLabel
Cardiac remodelling in end sta ...... fect of ACE inhibitors on MMP.
@ast
Cardiac remodelling in end sta ...... fect of ACE inhibitors on MMP.
@en
P2093
P2860
P356
P1433
P1476
Cardiac remodelling in end sta ...... fect of ACE inhibitors on MMP.
@en
P2093
P2860
P304
P356
10.1136/HEART.88.5.525
P407
P577
2002-11-01T00:00:00Z